Compare GRFS & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | NOV |
|---|---|---|
| Founded | 1940 | 1862 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.7B |
| IPO Year | 2006 | 1996 |
| Metric | GRFS | NOV |
|---|---|---|
| Price | $9.48 | $18.42 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 13 |
| Target Price | $10.15 | ★ $16.62 |
| AVG Volume (30 Days) | 467.0K | ★ 4.7M |
| Earning Date | 07-28-2022 | 02-04-2026 |
| Dividend Yield | 1.54% | ★ 1.64% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.64 | ★ 1.00 |
| Revenue | ★ $8,821,017,248.00 | $8,775,000,000.00 |
| Revenue This Year | $5.36 | N/A |
| Revenue Next Year | $5.15 | N/A |
| P/E Ratio | ★ $17.84 | $18.42 |
| Revenue Growth | ★ 7.31 | N/A |
| 52 Week Low | $6.19 | $10.84 |
| 52 Week High | $11.14 | $19.22 |
| Indicator | GRFS | NOV |
|---|---|---|
| Relative Strength Index (RSI) | 57.30 | 60.90 |
| Support Level | $9.12 | $18.18 |
| Resistance Level | $9.30 | $19.20 |
| Average True Range (ATR) | 0.21 | 0.55 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 91.74 | 54.12 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.